text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 23672-07-3 | Product Number: I0821

(S)-(-)-Sulpiride


Purity: >98.0%(T)(HPLC)
Synonyms:
  • (S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide
  • Levosulpiride
Documents:
5G
£48.00
Contact Us 2  
25G
£125.00
1   4  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number I0821
Purity / Analysis Method >98.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__1__5H__2__3N__3O__4S = 341.43 
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
CAS RN 23672-07-3
Reaxys Registry Number 3563418
PubChem Substance ID 135726922
Merck Index (14) 8989
MDL Number

MFCD00055220

Specifications
Appearance White to Light yellow powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(Nonaqueous Titration) min. 98.0 %
Melting point 185.0 to 189.0 °C
Specific rotation [a]20/D -67.0 to -71.0 deg(C=3, DMF)
Properties (reference)
Melting Point 187 °C
Specific Rotation -69° (C=3,DMF)
Solubility (soluble in) Dimethylformamide
GHS
Related Laws:
RTECS# BZ3400100
Transport Information:
HS Number 2935909099
Application
(S)-(-)-Sulpiride: A Dopamine D2 Receptor Antagonist

(S)-(-)-Sulpiride (or levosulpiride) is the active enantiomer of (±)-sulpiride [S0501], and a substituted benzamide-type atypical antipsychotic having the properties of dopamine D2 receptor antagonist. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents